Related Experiment Video

Updated: Aug 4, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Potassium Channels, Sulphonylurea Receptors and Control of Insulin Release

Dunne1, Cosgrove, Shepherd

  • 1Institute of Molecular Physiology and Department of Biomedical Science, The University of Sheffield, Western Bank, Sheffield, UK S10 2TN.

Trends in Endocrinology and Metabolism: TEM
|May 14, 1999
PubMed

Insights

Defects in ATP-sensitive K+ (KATP) channels cause insulin hypersecretion in infancy and may predispose to Type 2 diabetes. These channels are crucial for glucose regulation and understanding diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) and diabetes mellitus present opposing clinical profiles of insulin secretion.
  • Recent research links rare neonatal conditions like PHHI to cellular dysfunction relevant to diabetes.
  • The ATP-sensitive K+ (KATP) channel in pancreatic beta cells is central to glucose sensing and implicated in these disorders.

Purpose of the Study:

  • To explore the role of KATP channel genetics and function in glucose regulation disorders.
  • To elucidate the connection between KATP channel defects and both hyperinsulinemic hypoglycemia and diabetes.
  • To integrate genetic, cellular, and molecular insights into KATP channel dysfunction.

Main Methods:

  • Investigated the genetics of KATP channel defects.
  • Analyzed the cellular and molecular biology of KATP channels.
  • Examined the link between KATP channel function and insulin secretion/glucose regulation.

Main Results:

  • Defects in KATP channel genes lead to excessive insulin secretion (hyperinsulinemia).
  • KATP channel dysfunction can predispose individuals to Type 2 diabetes.
  • Acquired loss of KATP channel function is associated with maturity onset diabetes of the young and reactive hypoglycemia.

Conclusions:

  • KATP channels are critical regulators of insulin secretion and glucose homeostasis.
  • Understanding KATP channel function provides insights into the pathogenesis of both hypoglycemia and diabetes.
  • Genetic and acquired defects in KATP channels represent key mechanisms in various glucose dysregulation disorders.

More Related Videos

Confocal Imaging of Neuropeptide Y-pHluorin: A Technique to Visualize Insulin Granule Exocytosis in Intact Murine and Human Islets09:41

Confocal Imaging of Neuropeptide Y-pHluorin: A Technique to Visualize Insulin Granule Exocytosis in Intact Murine and Human Islets

Published on: September 13, 2017

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...